LivaNova’s (LIVN) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of LivaNova (NASDAQ:LIVN) in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a $75.00 price target on the stock.

A number of other research firms have also recently commented on LIVN. StockNews.com cut LivaNova from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 16th. The Goldman Sachs Group started coverage on shares of LivaNova in a report on Friday, October 4th. They issued a “buy” rating and a $65.00 target price on the stock. Mizuho cut their target price on shares of LivaNova from $80.00 to $70.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Baird R W upgraded shares of LivaNova from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, September 17th. Finally, Robert W. Baird raised their price objective on LivaNova from $66.00 to $72.00 and gave the company an “outperform” rating in a research report on Thursday, October 31st. One analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $69.17.

LivaNova Price Performance

Shares of LivaNova stock opened at $52.48 on Monday. The company has a market capitalization of $2.85 billion, a price-to-earnings ratio of 124.95 and a beta of 1.01. The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46. The stock’s 50-day simple moving average is $52.24 and its 200-day simple moving average is $52.30. LivaNova has a 52 week low of $42.75 and a 52 week high of $64.47.

Institutional Trading of LivaNova

A number of large investors have recently made changes to their positions in LIVN. Sanctuary Advisors LLC purchased a new position in shares of LivaNova in the 3rd quarter worth approximately $219,000. Geode Capital Management LLC lifted its position in LivaNova by 0.6% in the third quarter. Geode Capital Management LLC now owns 1,344,949 shares of the company’s stock worth $70,676,000 after buying an additional 8,331 shares during the last quarter. XTX Topco Ltd purchased a new position in LivaNova during the third quarter worth $550,000. Point72 DIFC Ltd increased its position in LivaNova by 75,799.6% during the third quarter. Point72 DIFC Ltd now owns 181,400 shares of the company’s stock valued at $9,531,000 after acquiring an additional 181,161 shares during the last quarter. Finally, Point72 Asset Management L.P. raised its stake in shares of LivaNova by 62.7% in the third quarter. Point72 Asset Management L.P. now owns 2,092,010 shares of the company’s stock valued at $109,914,000 after acquiring an additional 806,374 shares during the period. 97.64% of the stock is currently owned by institutional investors.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.